Key result
Excess visceral adipose tissue is independently linked to worse LV diastolic function in type 2 diabetes.
Why the study?
Clinical factors other than glycemic control that influence abnormal cardiac function in patients with type 2 diabetes mellitus were not well understood.
Do clinical factors such as visceral adipose tissue influence abnormal cardiac structure and function more than glycemic control in asymptomatic patients with type 2 diabetes mellitus?
Cohort (n=216)
No
Do clinical factors such as visceral adipose tissue influence abnormal cardiac structure and function more than glycemic control in asymptomatic patients with type 2 diabetes mellitus?
Effect estimate: β = -0.354
p-value: p=<0.001
Excessive visceral fat may play a greater role than glycemic control in the development of diastolic dysfunction and left ventricular hypertrophy in patients with type 2 diabetes mellitus.
Visceral adiposity may underlie diastolic dysfunction in asymptomatic T2DM beyond glycemia; hypothesis-generating for targeted interventions in prospective trials.
BACKGROUND: We hypothesized that clinical factors other than glycemic control may influence abnormal cardiac function in patients with type 2 diabetes mellitus (T2DM). We aimed to investigate the independent factors for abnormal cardiac function among clinical factors in T2DM. METHODS: We studied 148 asymptomatic patients with T2DM without overt heart disease. Echocardiographic findings were compared between diabetic patients and 68 age-matched healthy subjects. Early (E) and late (A) diastolic mitral flow velocity and early diastolic mitral annular velocity (e') were measured for assessing left ventricular (LV) diastolic function. We evaluated insulin resistance, non-esterified fatty acid, high-sensitive CRP, estimated glomerular filtration rate, waist/hip ratio, abdominal visceral adipose tissue (VAT), subcutaneous adipose tissue (SAT) and other clinical characteristics in addition to glycemic control. VAT and SAT were quantified by computed tomography. RESULTS: In T2DM, E/A and e' were significantly lower, and E/e', left atrial volume and LV mass were significantly greater than in control subjects. In multivariate liner regression analysis, VAT was an independent determinant of left atrial volume (β =0.203, p=0.011), E/A (β =-0.208, p=0.002), e' (β =-0.354, p<0.001) and E/e' (β=0.220, p=0.003). Age was also an independent determinant, whereas fasting plasma glucose and hemoglobin A1c levels were not. In addition to systolic blood pressure, waist-hip ratio (β=0.173, p=0.024) and VAT/SAT ratio (β=0.162, p=0.049) were independent determinants of LV mass. CONCLUSION: Excessive visceral fat accompanied by adipocyte dysfunction may play a greater role than glycemic control in the development of diastolic dysfunction and LV hypertrophy in T2DM.
No takes yet. Share an insight, caveat, or question.
Ichikawa et al. (2013) conducted a cohort in Type 2 diabetes mellitus (n=216). Visceral adipose tissue (VAT) vs. Other clinical factors (e.g., glycemic control) was evaluated on Left ventricular diastolic function (e' velocity) (β = -0.354, p=<0.001). Excessive visceral adipose tissue was an independent determinant of left ventricular diastolic dysfunction (e' β=-0.354, p<0.001) in patients with type 2 diabetes, playing a greater role than glycemic control.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: